8,298,546 |
10/30/12 |
ISOLATION AND PURIFICATION OF P. FALCIPARUM MEROZOITE PROTEIN 142 VACCINE |
WRAIR |
|
JEFFREY A. LYON; EVELINA ANGOV |
8,258,280 |
09/04/12 |
PLASMODIUM VIVAX HYBRID CIRCUMSPOROZOITE PROTEIN AND VACCINE |
WRAIR |
|
GEORGE C. KRAMER; JOSE SALINAS; GUY A. DREW |
8,211,447 |
07/03/12 |
RECOMBINANT P. FALCIPARUM MEROZOITE PROTEIN-142 VACCINE |
WRAIR |
|
EVELINA ANGOV; CHRISTIAN A. DARKO; JEFFREY A. LYON; JOSEPH D. COHEN |
8,183,358 |
05/22/12 |
PUUMALA VIRUS FULL-LENGTH M SEGMENT-BASED DNA VACCINES |
RIID |
|
JAY W. HOOPER |
8,153,397 |
04/10/12 |
RECOMBINANT LIGHT CHAINS OF BOTULINUM NEUROTOXINS AND LIGHT CHAIN FUSION PROTEINS FOR USE IN RESEARCH AND CLINICAL THERAPY |
RIID |
|
LEONARD A. SMITH; MICHAEL P. BYRNE |
8,067,202 |
11/29/11 |
BACTERIAL SUPERANTIGEN VACCINES |
RIID |
|
ULRICH, R. |
7,790,181 |
09/07/10 |
LIVE ATTENUATED VIRAL VACCINES FOR EASTERN EQUINE ENCEPHALITIS VIRUS |
RIID |
|
PLATTEBORZE, P.; PARKER, M. |
7,790,182 |
09/07/10 |
PROTEIN VACCINES AGAINST POXVIRUSES |
RIID |
|
HOOPER, J.; FRANCHINI, G. |
7,790,186 |
09/07/10 |
PLASMODIUM VIVAX HYBRID CIRCUMSPOROZOITE PROTEIN AND VACCINE |
WRAIR |
|
YADAVA, A.; OCKENHOUSE, C. |
7,786,285 |
08/31/10 |
RECOMBINANT VACCINE AGAINST BOTULINUM NEUROTOXIN |
RIID |
|
SMITH, L.; BYRNE, M.; MIDDLEBROOK, J.; LAPENOTIERE, H.; CLAYTON, M.; BROWN, D. |
7,759,106 |
07/20/10 |
CONSTRUCTION OF LIVE ATTENUATED SHIGELLA VACCINE STRAINS THAT EXPRESS CFA/I ANTIGENS (CFAB AND CFAE) AND THE B SUBUNIT OF HEAT-LABILE ENTEROTOXIN (LTB) FROM ENTEROTOXIGENIC E. COLI |
WRAIR |
|
RANALLO, R.; VENKATESAN, M. |
7,750,132 |
07/06/10 |
ALTERED SUGERANTIGEN TOXINS |
RIID |
|
ULRICH, R. |
7,736,656 |
06/15/10 |
IMMUNOGENIC COMPOSITIONS AND VACCINES FOR EBOLA |
RIID |
|
HART, M.; OLINGER, JR. G.: BAILEY, M. |
7,731,975 |
06/08/10 |
CHIMERIC FILOVIRUS GLYCOPROTEIN |
RIID |
|
GROGAN, C.; HEVEY, M.; SCHMALJOHN, A. |
7,722,889 |
05/25/10 |
PLASMODIUM LIVER STAGE ANTIGENS |
WRAIR |
|
DUFFY, P.; KRZYCH, U.; HEPPNER, D. JR.; MALKOV, V.; WENDLER, J.; BACIK, I. |
7,718,779 |
05/18/10 |
PROPHYLACTIC AND THERAPEUTIC MONOCLONAL ANTIBODIES |
RIID |
|
CHANH, T.; ADAMOVICZ, J.; ANDREWS, G.; POWELL, B. |
7,682,618 |
03/23/10 |
GENERATION OF VIRUS-LIKE PARTICLES AND USE AS PANFILOVIRUS VACCINE |
RIID |
|
BAVARI, S.; AMAN, M.; SCHMALJOHN, A.; WARFIELD, K.; SWENSON, D. |
7,678,828 |
03/16/10 |
METHODS FOR THE FORMULATION AND MANUFACTURE OF ARTESUNIC ACID FOR INJECTION |
WRAIR |
|
ELLIS, W.; LIM, P.; MANIAR, M. |
7,666,404 |
02/23/10 |
GLANDERS/MELIODOSIS VACCINES |
RIID |
|
ULRICH, R.; JEDDELOH, J.; OYSTON, P. |
7,655,247 |
02/02/10 |
MALARIA VACCINES |
WRAIR |
|
FRIED, M.; DUFFY, P.; FRANCIS, S.; WENDLER, J.; MUTABINGWA, T.; OLEINIKOV, A. |
7,625,571 |
12/01/09 |
TRANSFORMED BACTERIA PRODUCING CS6 ANTIGENS AS VACCINES |
WRAIR |
|
WOLF, M.; CASSELS, F., BOEDEKER, E. |
7,604,811 |
10/20/09 |
ORAL-INTESTINAL VACCINES AGAINST DISEASES CAUSED BY ENTEROPATHIC ORGANISMS USING ANTIGENS ENCAPSULATED WITHIN BIODEGRADEABLE- BIOCOMPATIBLE MICROSPHERES |
WRAIR |
|
JARBOE, D.; REID, R.; BOEDEKER, E.; CASSELS, F. |
7,595,191 |
09/29/09 |
ISOLATION AND PURIFICATION OF P. FALCIPARUM MEROZOITE PROTEIN-142 VACCINE |
WRAIR |
|
LYON, J.; ANGOV, E. |
7,574,340 |
08/11/09 |
SMALL MOLECULES AND A PHARMACOPHORE MODEL FOR INHIBITION OF BOTULINUM TOXIN AND METHODS OF MAKING AND USING THEREOF |
RIID |
|
BAVARI, S.; SCHMIDT, J.; BURNETT, J.; GUSSIO, R. |
7,563,883 |
07/21/09 |
RECOMBINANT P. FALCIPARUM MEROZOITE PROTEIN-142 VACCINE |
WRAIR |
|
ANGOV, E.; LYON, J., DARKO , C.; COHEN, J. |
7,550,275 |
06/23/09 |
EXPRESSION, PURIFICATION AND USES OF A PLASMODIUM FALCIPARUM LIVER STAGE ANTIGEN 1 POLYPEPTIDE |
WRAIR |
|
LANAR, D.; HILLIER, C.; LYON, J.; ANGOV, E.; KUMAR, S.; ROGERS, W.; BARBOSA, A. |
7,527,802 |
05/05/09 |
VACCINE FOR TRANSCUTANEOUS IMMUNIZATION |
WRAIR |
|
GLENN, G.; CASSELS, F. |
7,407,935 |
08/05/08 |
RICIN TOXIN A-CHAIN FRAGMENT FOR USE AS A VACCINE |
RIID |
|
OLSON, M; MILLARD, C; BYRNE, M; WANNEMACHER, R. |
7,378,257 |
05/27/08 |
BACTERIAL SUPERANTIGEN VACCINES |
RIID |
|
ULRICH, R; OLSON, M; BAVARI, S. |
7,374,931 |
05/20/08 |
VACCINE AGAINST STAPHYLOCOCCUS INTOXICATION |
RIID |
|
LEE, J; PUSHKO, P; SMITH, J; ULRICH, R. |
7,351,435 |
04/01/08 |
DEGLYCOSYLATED RICIN TOXIN A-CHAIN VACCINE |
RIID |
|
WANEMACHER, R; HEWETSON, J. |
7,332,172 |
02/19/08 |
TRANSFORMED BACTERIA PRODUCING C6 ANTIGENS AS VACCINES |
WRAIR |
|
WOLF, M.; CASSELS, F.; BOEDEKER, E. |
7,306,806 |
12/11/07 |
RECOMBINANT P. FALCIPARUM MEROZOITE PROTEIN-142 VACCINE |
WRAIR |
|
LYON, J.; ANGOV, E.; COHEN, J.; VOSS, G. |
7,256,281 |
08/14/07 |
RECOMBINANT P. FALCIPARUM MEROZOITE PROTEIN-1.SUB.42 VACCINE |
WRAIR |
|
ANGOV, E.; DARKO, C.; LYON, J.; COHEN, J. |
7,235,644 |
06/26/07 |
VACCINE AGAINST GRAM-NEGATIVE BACTERIAL INFECTIONS |
WRAIR |
|
BHATTACHARJEE, A.; CROSS, A.; SADOFF, J.; ZOLLINGER, W. |
7,217,418 |
05/17/07 |
MULTIVALENT DENGUE VIRUS VACCINE |
WRAIR |
|
ECKELS, K. ; PUTNAK, J. ; DUBOIS, D. ; INNIS, B. ; HOKE, C. ; SUN, W.; KANESA-THASAN, N. |
7,217,812 |
05/15/07 |
EXTRANEOUS DNA SEQUENCE THAT FACILITATES HANTAVIRUS GENE EXPRESSION |
WRAIR |
|
HOOPER, J.; SCHMALJOHN, C.; CUSTER, M. |
7,101,902 |
09/05/06 |
2-GUANIDINYLIMIDAZOLIDINEDIONE COMPOUNDS AND METHODS OF MAKING AND USING THEREOF |
WRAIR |
|
LIN, A.; ZHANG, Q.; GUAN, J.; MILHOUS, W. |
7,090,852 |
08/15/06 |
VENEZUELAN EQUINE ENCEPHALITIS VIRUS REPLICON ENCODING MARBURG VIRUS PROTEINS |
RIID |
|
HEVEY, M.; NEGLEY, D.; PUSHKO, P.; SMITH, J.; SCHMALJOHN, A. |
7,025,963 |
04/11/06 |
VACCINE AGAINST GRAM-NEGATIVE BACTERIAL INFECTIONS |
WRAIR |
|
BHATTACHARJEE, A.; CROSS, A.; SADOFF, J.; ZOLLINGER, W. |
7,018,636 |
03/28/06 |
VACCINE AGAINST GRAM-NEGATIVE BACTERIAL INFECTIONS |
WRAIR |
|
BHATTACHARJEE, A.; CROSS, A.; SADOFF, J.; ZOLLINGER, W. |
6,902,743 |
06/07/05 |
THERAPEUTIC TREATMENT AND PREVENTION OF INFECTIONS WITH A BIOACTIVE MATERIAL(S) ENCAPSULATED WITHIN A BIODEGRADABLE-BIO-COMPATIBLE POLYMERIC MATRIX |
WRAIR |
|
SETTERSTROM, J.; TICE, T., JACOB, E., REID, R.; VAN HAMMONT, J.; BOEDECKER, E., JEYANTHI, R.; FRIDEN, P.; ROBERTS, D.; MCQUEEN, C.; BHATTACHARJEE, A.; CROSS, A.; SADOFF, J; ZOLLINGER, W. |
6,872,398 |
03/29/05 |
CONJUGATE VACCINE AGAINST GRAM-NEGATIVE BACTERIAL INFECTION |
WRAIR |
|
CASTRIC, P; CROSS, A; SADOFF, J. |
6,869,787 |
03/22/05 |
RICIN VACCINE AND METHODS OF MAKING AND USING THEREOF |
RIID |
|
OLSON, M.; MILLARD, C.; BYRNE, M.; WANNEMACHER, R.; LECLAIRE, R. |
6,855,322 |
02/15/05 |
ISOLATION AND PURIFICATION OF P. FALCIPARUM MEROZOITE PROTEIN-142 VACCINE |
WRAIR |
|
LYON, J.; ANGOV, E. |
6,770,479 |
08/03/04 |
ANTHRAX VACCINE |
RIID |
|
LEE, J.; PUSHKO, P.; PARKER, M.; SMITH, J.; WELKOS, S. |
6,632,640 |
10/14/03 |
VACCINE AGAINST STAPHYLOCOCCUS INTOXICATION |
RIID |
|
LEE, J.; PUSHKO, P.; SMITH, J.; ULRICH, R. |
6,562,376 |
05/13/03 |
DNA VACCINES AGAINST POXVIRUSES |
RIID |
|
HOOPER, J.; SCHMALJOHN, A.; SCHMALJOHN, C. |
6,558,677 |
05/06/03 |
VACCINE AGAINST GRAM NEGATIVE BACTERIA |
WRAIR |
|
ZOLLINGER, W.; SHOEMAKER, D.; SAUNDERS, A.; BRANDT, B. |
6,541,010 |
04/01/03 |
ALPHAVIRUS RNA REPLICON SYSTEMS |
RIID |
|
JOHNSTON, R.; DAVIS, N.; SMITH, J.; PUSHKO, P.; PARKER, M.; LUDWIG, G. |
6,517,842 |
02/11/03 |
MARBURG VIRUS VACCINE |
RIID |
|
HEVEY, M.; NEGLEY, D.; PUSHKO, P.; SMITH, J.; SCHMALJOHN; A. |
6,514,501 |
02/04/03 |
RECOMBINANT VACCINE AGAINST DENGUE VIRUS |
WRAIR |
|
KELLY, E.; KING, A. |
6,495,143 |
12/17/02 |
BOTULINUM NEUROTOXIN VACCINE |
RIID |
|
LEE, J.; PUSHKO, P.; SMITH, J.; PARKER, M.; DERTZBAUGH, M.; SMITH, L. |
6,309,650 |
10/30/01 |
ATTENUATED JAPANESE ENCEPHALITIS VIRUS ADAPTED TO VERO CELLS AND A JAPANESE ENCEPHALITIS VACCINE |
WRIAR |
|
KIM, H.; YOO, W.; KIM, S.; LEE, S.; MOON, S.; HONG, S.; SHIN, Y.; CHUNG, Y.; ECKELS, K.; INNIS, B.; PUNIAK, J.; BINN, L.; SRIVASTAVA, A.; DUBOIS, D. |
6,261,567 |
07/17/01 |
OVERCOMING INTERFERENCE IN ALPHAVIRUS IMMUNE INDIVIDUALS |
RIID |
|
HART, M.; AZARION, M. |
6,258,788 |
07/10/01 |
DNA VACCINES AGAINST TICK-BORNE FLAVIVIRUSES |
RIID |
|
SCHMALJOHN, C. |
6,254,873 |
07/03/01 |
INACTIVATED DENGUE VIRUS VACCINE |
WRAIR |
|
PUTNAK, J.; ECKELS, K.; DUBOIS, D. |
6,200,959 |
03/13/01 |
GENETIC INDUCTION OF ANTI-VIRAL IMMUNE RESPONSE AND GENETIC VACCINE FOR FILOVIRUS |
RIID |
|
HAYNES, J.; SCHMALJOHN, C.; FULLER, D.; SCHMALJOHN, A.; JAHRLING, P. |
6,117,640 |
09/12/00 |
RECOMBINANT VACCINE MADE IN E. COLI AGAINST DENGUE VIRUS |
WRAIR |
|
SRIVASTAVA, A.; PUTNAK, J.; HOKE, C.; WARREN, R. |
6,074,865 |
06/13/00 |
RECOMBINANT DENGUE VIRUS DNA FRAGMENT |
WRAIR |
|
KELLY, E.; KING, A. |
5,762,965 |
06/09/98 |
VACCINES AGAINST INTRACELLULAR PATHOGENS USING ANTIGENS ENCAPSULATED WITHIN BIODEGRADABLE BIOCOMPATIBLE MICROSPHERES |
WRAIR |
|
BURNETT, P.; VAN HAMONT, J.; REID, R.; SETTERSTROM, J.; VAN COTT, T.; BIRX, D. |
5,614,193 |
03/25/97 |
HANTAVIRUS VACCINE |
RIID |
|
SCHMALJOHN, C.; MCCLAIN, D.; DALRYMPLE, J. |
5,453,271 |
09/26/95 |
VACCINE AGAINST RICIN TOXIN |
RIID |
|
LEMLEY, P.; CREASIA, D. |
5,298,423 |
03/29/94 |
NUCLEOTIDE SEQUENCES ENCODING THE EXPRESSION OF A HANTAAN VIRUS NUCELOCAPSID PROTEIN AND G1 AND G2 GLYCOPROTEINS |
RIID |
|
DALRYMPLE, J.; SCHMALJOHN, C. |